Dr Jens C Nielsen (Aarhus University Hospital, Denmark) discusses DANPACE: the Danish multicenter randomized trial on single-lead atrial vs dual chamber pacing in sick sinus syndrome. Recorded at the ESC convention center in Stockholm, Sweden on Sunday, August 29.

Dr Andreas Goette (Otto-von-Guericke-University Hospital, Magdeburg, Germany) discusses ANTIPAF: angiotensin II-antagonist in paroxysmal atrial fibrillation trial. Recorded at the ESC convention center in Stockholm, Sweden on Tuesday, August 31.

Dr Stuart Connolly (McMaster University, Hamilton, ON) discusses AVERROES: apixaban vs acetylsalicylic acid to prevent strokes. Recorded at the ESC convention center in Stockholm, Sweden on Monday, August 30.

Dr Sanjit Jolly (McMaster University, Hamilton, ON) discusses FUTURA OASIS 8: a randomized trial comparing two regimens of adjunctive intravenous unfractionated heparin during PCI in high-risk patients with non-STE-ACS treated with fondaparinux. Recorded at the ESC convention center in Stockholm, Sweden on Tuesday, August 31.

Dr Ron J Peters (University of Amsterdam, the Netherlands) discusses RESPONSE: effect of a nurse-coordinated prevention program on cardiovascular risk after an acute coronary syndrome. Recorded at the ESC convention center in Stockholm, Sweden on Tuesday, August 31.

Dr Shinya Goto (Tokai University, Isehara, Japan) discusses the double-blind, placebo-controlled phase 2 studies of E5555 in Japanese patients with ACS and CAD. Recorded at the ESC convention center in Stockholm, Sweden on Tuesday, August 31.

Dr David P Taggart (John Radcliffe Hospital, Oxford, UK) discusses ART: a randomised trial to compare survival following bilateral vs single internal mammary grafting in coronary revascularization. Recorded at the ESC convention center in Stockholm, Sweden on Monday, August 30

Dr A Voors (University Medical Center Groningen, the Netherlands) discusses HEBE III: a single dose of erythropoietin in ST-elevation myocardial infarction. Recorded at the ESC convention center in Stockholm, Sweden on Monday, August 30.

Dr Sunil Rao (Duke University Medical Center, Durham, NC) discusses the state of the art of PCI including information on SAFE PCI for women. Recorded at the ESC convention center in Stockholm, Sweden on Monday, August 30.

Dr Sunil Rao (Duke University Medical Center, Durham, NC) discusses Bleeding Academic Research Consortium (BARC). Recorded at the ESC convention center in Stockholm, Sweden on Monday, August 30.

Dr Sunil Rao (Duke University Medical Center, Durham, NC) discusses INNOVATE PCI: a phase 2 safety and efficacy study of PRT060128 (elinogrel), a novel intravenous and oral P2Y12 inhibitor. Recorded at the ESC convention center in Stockholm, Sweden on Monday, August 30.

Dr Gilles Montalescot (Hôpital Pitié-Salpêtrière, Paris, France) discusses ISAR-REACT 3A and his thoughts on the right dose of heparin. Recorded at the ESC convention center in Stockholm, Sweden on Monday, August 30

Dr Gilles Montalescot (Hôpital Pitié-Salpêtrière, Paris, France) discusses his meta-analysis of new thienopyridines. Recorded at the ESC convention center in Stockholm, Sweden on Monday, August 30.

Dr Gilles Montalescot (Hôpital Pitié-Salpêtrière, Paris, France) discusses ATOLL: an international, randomized trial comparing IV enoxaparin with IV unfractionated heparin in primary PCI for ST-elevation myocardial infarction. Recorded at the ESC convention center in Stockholm, Sweden on Monday, August 30.

Dr Daan Kromhout (Wageningen University, the Netherlands) discusses ALPHA OMEGA: the effect of low doses of n-3 fatty acids on cardiovascular diseases in post-MI patients. Recorded at the ESC convention center in Stockholm, Sweden on Sunday, August 29.

Dr Bertram Pitt (University of Michigan, Ann Arbor) discusses PEARL HF: a multicenter, randomized, double-blind, placebo-controlled, parallel-group, multiple-dose study to evaluate the effects of RLY5016 in heart-failure patients. Recorded at the ESC convention center in Stockholm, Sweden on Sunday, August 29.

Clopidogrel loading dose adjustment according to platelet-reactivity monitoring in patients carrying the 2C19 2 loss-of-function polymorphism with Dr Laurent Bonello (Hôpital Université Nord, Marseilles, France). Recorded at the ESC convention center in Stockholm, Sweden on Sunday, August 29.